Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCRTR1 | O43613 | 4/20 | 0.36 |
| ▸ | HCRTR2 | O43614 | 4/20 | 0.36 |
| ▸ | BACE1 | P56817 | 2/20 | 0.36 |
| ▸ | CPT1A | P50416 | 11/20 | 0.35 |
| ▸ | CPT2 | P23786 | 10/20 | 0.35 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.35 |
| ▸ | CPT1B | Q92523 | 4/20 | 0.34 |
| ▸ | AADAT | Q8N5Z0 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2727057 | 1.00 | HCRTR1 (0.36) | HCRTR1HCRTR2BACE1CPT1ACPT2 | |
| Fumaric Acid SCHEMBL2732806 | 0.97 | BACE1 (0.35) | HCRTR1HCRTR2BACE1CPT1ACPT2 | |
| SCHEMBL2728291 | 0.93 | CPT1A (0.35) | HCRTR1HCRTR2CPT1ACPT2TRPV1 | |
| SCHEMBL2726356 | 0.92 | TRPV1 (0.35) | HCRTR1HCRTR2CPT1ACPT2TRPV1 | |
| SCHEMBL2726488 | 0.91 | BACE1 (0.39) | HCRTR1HCRTR2BACE1CPT1ACPT2 | |
| SCHEMBL2726490 | 0.91 | BACE1 (0.39) | HCRTR1HCRTR2BACE1CPT1ACPT2 | |
| SCHEMBL2726485 | 0.91 | BACE1 (0.39) | HCRTR1HCRTR2BACE1CPT1ACPT2 | |
| SCHEMBL2725211 | 0.90 | BACE1 (0.40) | HCRTR1HCRTR2BACE1CPT1ACPT2 | |
| SCHEMBL2726641 | 0.90 | HCRTR1 (0.38) | HCRTR1HCRTR2BACE1CPT1ACPT2 | |
| SCHEMBL6465777 | 0.90 | BACE1 (0.40) | HCRTR1HCRTR2BACE1CPT1ACPT2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2012054510-A1 | OXADIAZOLE COMPOUNDS WHICH INHIBIT BETA-SECRETASE ACTIVITY AND METHODS OF USE THEREOF | COMENTIS, INC. (US) | 2012-04-26 | — | — | WO | claimed |